Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Ran Ding

Ran Ding publishes mostly in Surgery, Molecular Biology and Biomedical Engineering, on topics such as Lung Cancer Treatments and Mutations, Radiomics and Machine Learning in Medical Imaging and Total Knee Arthroplasty Outcomes.

ORCID 0000-0002-7453-8968 OpenAlex
World rank
#2,531,811
of 7,710,434 ranked researchers
Rank in China
#396,047
of 978,568
Works
163
Citations
1.7k
Citations per work
10.6
h-index
22
i10-index 47Top 13% in Surgery
Ran Ding

What does Ran Ding research?

Ran Ding's work is mostly in Medicine (20%), Biochemistry, Genetics and Molecular Biology (14%), Engineering (6%).

Everything else: 99 works · 61.0% of their workHealth Sciences: 32 works · 19.7% of their workMedicine: 32 works · 19.7% of their workSurgery: 18 works · 11.0% of their workPulmonary and Respiratory Medicine: 8 works · 4.9% of their workOncology: 6 works · 3.8% of their workLife Sciences: 22 works · 13.7% of their workBiochemistry, Genetics and Molecular Biology: 22 works · 13.7% of their workMolecular Biology: 15 works · 9.2% of their workCancer Research: 7 works · 4.5% of their workPhysical Sciences: 9 works · 5.6% of their workEngineering: 9 works · 5.6% of their workBiomedical Engineering: 9 works · 5.6% of their workTHEIR WORKRan Ding163works
Life Sciences14%Physical Sciences6%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else9961.0%
    1. Medicine3219.7%
    1. Biochemistry, Genetics and Molecular Biology2213.7%
    1. Engineering95.6%
  1. 1Surgery11% of their works
  2. 2Molecular Biology9% of their works
  3. 3Biomedical Engineering6% of their works
  4. 4Pulmonary and Respiratory Medicine5% of their works
  5. 5Cancer Research4% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Ran Ding's research?

The keywords of their largest research topics: Targeted Therapy, Precision Medicine, Revision Surgery, Total Hip Replacement, ALK Inhibitors, Arthroplasty, EGFR Mutations and Medical Imaging.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy172 topics
  2. Precision Medicine162 topics
  3. Revision Surgery152 topics
  4. Total Hip Replacement152 topics
  5. ALK Inhibitors91 topic
  6. Arthroplasty91 topic
  7. EGFR Mutations91 topic
  8. Medical Imaging91 topic
  9. Radiomics91 topic
  10. Total Knee Replacement91 topic
  11. Cancer Genomics81 topic
  12. Mutational Signatures81 topic
  13. Cetuximab71 topic
  14. KRAS Mutations71 topic
  15. Cortical Networks61 topic
  16. Hip Arthroplasty61 topic
  17. Neuronal Oscillations61 topic
  18. Wear Particles61 topic
  19. Neurotransmission51 topic
  20. Synaptic Plasticity51 topic

Where does Ran Ding work?

Ran Ding's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Ran Ding have?

OpenAlex counts 163 works and 1,727 citations for Ran Ding, an h-index of 22, ranking #2,531,811 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Ran Ding

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ran Ding. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.